Medical Genome Facility, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
BMC Genomics. 2020 Dec 11;21(1):890. doi: 10.1186/s12864-020-07304-4.
There are challenges in generating mRNA-Seq data from whole-blood derived RNA as globin gene and rRNA are frequent contaminants. Given the abundance of erythrocytes in whole blood, globin genes comprise some 80% or more of the total RNA. Therefore, depletion of globin gene RNA and rRNA are critical steps required to have adequate coverage of reads mapping to the reference transcripts and thus reduce the total cost of sequencing. In this study, we directly compared the performance of probe hybridization (GLOBINClear Kit and Globin-Zero Gold rRNA Removal Kit) and RNAse-H enzymatic depletion (NEBNext® Globin & rRNA Depletion Kit and Ribo-Zero Plus rRNA Depletion Kit) methods from 1 μg of whole blood-derived RNA on mRNA-Seq profiling. All RNA samples were treated with DNaseI for additional cleanup before the depletion step and were processed for poly-A selection for library generation.
Probe hybridization revealed a better overall performance than the RNAse-H enzymatic depletion method, detecting a higher number of genes and transcripts without 3' region bias. After depletion, samples treated with probe hybridization showed globin genes at 0.5% (±0.6%) of the total mapped reads; the RNAse-H enzymatic depletion had 3.2% (±3.8%). Probe hybridization showed more junction reads and transcripts compared with RNAse-H enzymatic depletion and also had a higher correlation (R > 0.9) than RNAse-H enzymatic depletion (R > 0.85).
In this study, our results showed that 1 μg of high-quality RNA from whole blood could be routinely used for transcriptional profiling analysis studies with globin gene and rRNA depletion pre-processing. We also demonstrated that the probe hybridization depletion method is better suited to mRNA sequencing analysis with minimal effect on RNA quality during depletion procedures.
从全血来源的 RNA 生成 mRNA-Seq 数据存在挑战,因为珠蛋白基因和 rRNA 是常见的污染物。由于全血中红细胞的丰富度,珠蛋白基因约占总 RNA 的 80%或更多。因此,耗尽珠蛋白基因 RNA 和 rRNA 是获得足够的参考转录本映射读数覆盖度的关键步骤,从而降低测序的总成本。在这项研究中,我们直接比较了探针杂交(GLOBINClear 试剂盒和 Globin-Zero Gold rRNA 去除试剂盒)和 RNA 酶 H 酶促耗尽(NEBNext® Globin & rRNA depletion 试剂盒和 Ribo-Zero Plus rRNA depletion 试剂盒)方法从 1μg 全血来源的 RNA 进行 mRNA-Seq 分析的性能。所有 RNA 样品在耗尽步骤之前都用 DNaseI 进行了额外的清洗,然后进行多聚 A 选择以生成文库。
探针杂交显示出比 RNA 酶 H 酶促耗尽方法更好的整体性能,检测到更多的基因和转录物,没有 3' 区域偏倚。耗尽后,用探针杂交处理的样品中珠蛋白基因占总映射读数的 0.5%(±0.6%);RNA 酶 H 酶促耗尽方法为 3.2%(±3.8%)。与 RNA 酶 H 酶促耗尽相比,探针杂交显示出更多的连接读取和转录物,并且与 RNA 酶 H 酶促耗尽的相关性也更高(R>0.9)(R>0.85)。
在这项研究中,我们的结果表明,1μg 高质量的全血 RNA 可以常规用于转录谱分析研究,在预处理中进行珠蛋白基因和 rRNA 耗尽。我们还证明,探针杂交耗尽方法更适合于 mRNA 测序分析,在耗尽过程中对 RNA 质量的影响最小。